by: Edward B. Mulligan V, Attorney On February 12, 2013, the federal Judicial Panel on Multidistrict Litigation (JPML) transferred some 134 cases ... Read More
Pharmaceutical Drug Litigation
Transparency Comes to Your Doctor’s Office via Affordable Healthcare Act
Pharmaceutical and medical device makers invest millions of dollars in the research and development of innovative treatments and cures to help improve ... Read More
Stengel v. Medtronic and Failure to Warn
by: Jonathan Knoll, Attorney On January 10, 2013, the United States Court of Appeals for the Ninth Circuit sitting en banc found that the Medical ... Read More
Biased Drug Trials and the Effect on Patients
What do you remember from your high school science class? You probably remember designing and conducting experiments. You might even remember the ... Read More
Industry Sponsorship of Drug and Device Trials Shows Bias
Is it possible for a drug or medical device manufacturer to conduct a study on the efficacy of its product without showing bias? Consider a study to ... Read More
Fungal Meningitis Outbreak Blame Goes to: NECC, Massachusetts Board of Pharmacy, or FDA?
The House Energy & Commerce subcommittee held a hearing on November 14, 2012 to gather the facts surrounding the fungal meningitis outbreak that ... Read More
